Versant Vantage I GP-GP, LLC's Net Worth

$40.5 Million

Who is Versant Vantage I GP-GP, LLC?

Versant Vantage I GP-GP, LLC has an estimated net worth of $40.5 Million. This is based on reported shares across multiple companies, which include Repare Therapeutics Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Pandion Therapeutics, Inc., Passage BIO, Inc., RayzeBio, Inc., and Aprea Therapeutics, Inc..

SEC CIK

Versant Vantage I GP-GP, LLC's CIK is 0001777653

Past Insider Trading and Trends

2021 was Versant Vantage I GP-GP, LLC's most active year for acquiring shares with 36 total transactions. Versant Vantage I GP-GP, LLC's most active month to acquire stocks was the month of May. 2021 was Versant Vantage I GP-GP, LLC's most active year for disposing of shares, totalling 62 transactions. Versant Vantage I GP-GP, LLC's most active month to dispose stocks was the month of December. 2019 saw Versant Vantage I GP-GP, LLC paying a total of $14,439,995.00 for 8,097,811 shares, this is the most they've acquired in one year. In 2022 Versant Vantage I GP-GP, LLC cashed out on 1,854,232 shares for a total of $9,188,775.00, their largest year based on trade value.